Describe Sugammadex in detail.

Definition & Mechanism

Sugammadex is a modified γ-cyclodextrin that reverses the aminosteroid non-depolarising relaxants — chiefly rocuronium (and vecuronium). Uniquely, it works by encapsulating (chelating) the relaxant molecule in the plasma, forming an inactive complex that is excreted renally; this removes the relaxant from the neuromuscular junction and rapidly reverses the block.

Advantages

Sugammadex provides rapid and complete reversal even of a profound (deep) block, which anticholinesterases cannot do. Because it does not act on acetylcholinesterase, it needs no antimuscarinic and lacks the muscarinic side-effects (bradycardia, secretions) of neostigmine. It can rescue a ‘can’t intubate’ situation after rocuronium by rapidly restoring neuromuscular function.

Doses & Limitations

Sugammadex is given in a dose matched to the depth of block — a small dose for routine reversal of a moderate block and a larger dose to reverse a profound block or for immediate rescue after a rapid-sequence dose of rocuronium — and it acts within a couple of minutes. Its limitations are that it is specific to the aminosteroid relaxants and does not reverse the benzylisoquinolinium agents such as atracurium, that it is relatively expensive, and that by binding some hormones it can transiently reduce the efficacy of hormonal contraceptives, about which patients are advised.

Note

Its specificity to the aminosteroids and its cost are the trade-offs for this rapid, reliable reversal.

Reverses even profound rocuronium block — unlike neostigmine.

• Sugammadex: modified cyclodextrin that encapsulates aminosteroid relaxants (rocuronium, vecuronium).
• Removes relaxant from the junction → rapid, complete reversal even of deep block.
• No effect on acetylcholinesterase → no antimuscarinic needed; no muscarinic side-effects.
• Can rescue a ‘can’t intubate’ situation after rocuronium.